Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 179Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Aspire Lifesciences Pvt Ltd

02 2Aurobindo Pharma Limited

03 2Eurofarma Laboratorios S.A.

04 1Grupo Azevedos

05 3Inventia Healthcare Limited

06 2Sudarshan Pharma

07 6Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Pellets

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

01

2024 ACI Convention
Not Confirmed
arrow

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Pellets

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

2024 ACI Convention
Not Confirmed
arrow

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Brazil

blank

05

2024 ACI Convention
Not Confirmed
arrow

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Coated Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Brazil

blank

06

2024 ACI Convention
Not Confirmed
arrow

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Tablets

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Portugal

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Dosage : Tablets

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Portugal

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : Extended Release Pelle...

Dosage Strength : 15.79% W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

2024 ACI Convention
Not Confirmed
arrow

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : Extended Release Capsu...

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Countries Registered In: US (F...

Registration Country : India

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : Extended Release Capsu...

Dosage Strength : 15MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : Extended Release Capsu...

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Countries Registered In: US (F...

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : Extended Release Capsu...

Dosage Strength : 30MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name : BENZOMAC 15

Dosage Form :

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine HCl

Brand Name : BENZOMAC 30

Dosage Form :

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine HCl

Dosage :

Dosage Strength : 30MG

Brand Name : BENZOMAC 30

Approval Date :

Application Number :

Registration Country : India

blank

13

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : ER Pellets

Dosage Strength : 15.79% W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

13

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : ER Pellets

Dosage Strength : 15.79% W/W

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

14

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : ER Pellets

Dosage Strength : 15.79% W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

14

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : ER Pellets

Dosage Strength : 15.79% W/W

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

15

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : ER Pellets

Dosage Strength : 15.79% W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

15

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : ER Pellets

Dosage Strength : 15.79% W/W

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

16

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Brand Name :

Dosage Form : ER Pellets

Dosage Strength : 15.79% W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country :

blank

16

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine Hydrochloride

Dosage : ER Pellets

Dosage Strength : 15.79% W/W

Brand Name :

Approval Date :

Application Number :

Registration Country :

blank

17

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Brazil

blank

17

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Dosage : Coated Tablet

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Brazil

blank

18

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Brand Name :

Dosage Form : Coated Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Brazil

blank

18

Country
2024 ACI Convention
Not Confirmed
arrow

Country
arrow
2024 ACI Convention
Not Confirmed

Cyclobenzaprine

Dosage : Coated Tablet

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Brazil

blank